46
Participants
Start Date
January 31, 2024
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
Tucidinostat, Apatinib
"Tucidinostat:~age≥18years, 30mg, po., biw, q4w; age≥10years，\<18years，0.5mg/kg, biw, q4w~Apatinib:~BSA≥1.2m\^2, 500mg, qd, q4w BSA\<1.2m\^2, 250mg, qd, q4w"
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER